Trending...
- Sinaloa Cartel Embraces Diversity and Inclusion in the Post-Chapo Era
- IntellaTriage Names Olivia Gaffney, RN as 2022 Nurse of the Year Honoree
- Ohio Pacing Stallion Catch The Fire Is Heading To Australia
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Harmony Biosciences Holdings, Inc. ("Harmony" or the "Company") (NASDAQ: HRMY) on behalf of investors concerning the Company's possible violations of federal securities laws.
If you are a shareholder who suffered a loss, click here to participate.
More on The Californer
On March 28, 2023, Scorpion Capital published a report alleging, among other things, that Harmony's narcolepsy drug, Wakix, has "alarming toxicity," "no efficacy," is based on "sham patents," and "scam clinical trials," and has been "pushed via false advertising and a vast off-label and physician kickback scheme."
On this news, Harmony's share price fell $10.70 per share, or 25.8%, to close at $30.80 per share on March 28, 2023, thereby injuring investors.
Follow us for updates on Twitter: twitter.com/FRC_LAW.
If you purchased Harmony securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Frank R. Cruz, of The Law Offices of Frank R. Cruz, 1999 Avenue of the Stars, Suite 1100, Los Angeles, California 90067 at 310-914-5007, by email to info@frankcruzlaw.com, or visit our website at www.frankcruzlaw.com. If you inquire by email please include your mailing address, telephone number, and number of shares purchased.
More on The Californer
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Contacts
The Law Offices of Frank R. Cruz, Los Angeles
Frank R. Cruz, 310-914-5007
fcruz@frankcruzlaw.com
www.frankcruzlaw.com
If you are a shareholder who suffered a loss, click here to participate.
More on The Californer
- InventHelp Inventor Develops Improved Holder for a Smartphone (OCC-1612)
- CUTR INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Cutera, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
- Levinger-Regens Analytics Reveals New Energy Outlook
- It's Time to Bring Back Pokémon Conquest Laceysx : Reigniting the Excitement and Nostalgia
- WO Accelerator Launches First Talent Platform for Producers and Screenwriters
On March 28, 2023, Scorpion Capital published a report alleging, among other things, that Harmony's narcolepsy drug, Wakix, has "alarming toxicity," "no efficacy," is based on "sham patents," and "scam clinical trials," and has been "pushed via false advertising and a vast off-label and physician kickback scheme."
On this news, Harmony's share price fell $10.70 per share, or 25.8%, to close at $30.80 per share on March 28, 2023, thereby injuring investors.
Follow us for updates on Twitter: twitter.com/FRC_LAW.
If you purchased Harmony securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Frank R. Cruz, of The Law Offices of Frank R. Cruz, 1999 Avenue of the Stars, Suite 1100, Los Angeles, California 90067 at 310-914-5007, by email to info@frankcruzlaw.com, or visit our website at www.frankcruzlaw.com. If you inquire by email please include your mailing address, telephone number, and number of shares purchased.
More on The Californer
- Socket Mobile Strengthens Balance Sheet with a Secured Subordinated Convertible Note Financing of $1.6 Million
- UVify Unveils the Groundbreaking SLAMDAQ
- Immediate Release Tina Turner & Little Richard Tribute
- InventHelp Inventor Develops Windows with Self-Adjusting Tint Capabilities (SDB-1615)
- California: Governor Newsom Proclaims Memorial Day 2023
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Contacts
The Law Offices of Frank R. Cruz, Los Angeles
Frank R. Cruz, 310-914-5007
fcruz@frankcruzlaw.com
www.frankcruzlaw.com
Filed Under: Business
0 Comments
Latest on The Californer
- AHEAD With Horses Announces Fun Day 2023
- prevention verses hospitalizations and/or emergency care., Dr.Abhay Kumar Pati, D.Sc
- 100FilmsRetreat.com Completed 1st Ever Event with Films from 59 Different Countries on 6 Continents
- California: Governor Newsom Announces New CalVet Secretary
- Les Franklin is back with what appears to be his best work thus far!
- Governor and First Partner Visit VA Campus, Meet with California Veterans
- Long Beach to Announce Inaugural Youth Poet Laureate and Poet Ambassadors
- Bioscience industry leader Guillermo Zuñiga receives honorary doctorate at Cal State LA Commencement
- SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in NextEra Energy, Inc. with Losses of $100,000 to Contact the Firm
- City of Long Beach Seeks Feedback on Procurement Process Via Vendor Engagement Survey
- ReadyCommunities Partnership of CCROA Announces National Service Awardees Who Helped Save Passengers from the Derailed Train Near Rural Mendon
- Sinaloa Cartel Embraces Diversity and Inclusion in the Post-Chapo Era
- 54 FOSTER YOUTH & FIRST-GENERATION COLLEGE GRADUATES EACH RECEIVE A SURPRISE $2,000 GIFT
- Rivian CFO to Participate in the Deutsche Bank Global Auto Industry Conference
- California Announces Nearly $200 Million to Build Resilience Centers to Protect Communities From Extreme Heat, Other Climate Impacts
- Youth Invited to Apply for Long Beach's Youth Advisory Council
- TEAMSTERS HALT WAYMO IN SAN FRANCISCO
- City of Long Beach Begins Payments for Long Beach Pledge Guaranteed Income Pilot Program
- INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Freshpet, Inc. and Encourages Investors with Losses to Contact the Firm
- TrustArc's 4th Annual Benchmarks Survey Reveals Strong Privacy Outcomes for Companies with Smart Governance Frameworks